Nuclera vs Twist Bioscience

Nuclera logo

Nuclera

Bring rapid protein access to your benchtop with eProtein Discovery

108 employees · est. 2013 · Cambridge, United Kingdom

VS
Twist Bioscience logo

Twist Bioscience

Synthetic DNA for Health & Sustainability

1317 employees · est. 2013 · South San Francisco, United...

Twist Bioscience is the larger of the two.

Side-by-Side Comparison

Nuclera Twist Bioscience
Founded
2013 2013
Headquarters
Cambridge, United Kingdom South San Francisco, United States
Employees
108 1317 larger
Industry
Biotechnology, Life Sciences, Pharmaceutical Biotechnology, Health Care, Life Sciences
Funding Stage
Series C IPO
Total Funding
$207.83M $943.10M
Funding Rounds
9 14
Services
eProtein Discovery System, Antibody Screening Services, Protein Design and Expression, Membrane Protein Production Gene Synthesis, Antibody Production and Characterization, Library Preparation Solutions, Variant Library Development, DNA Synthesis on Silicon Platform
Target Customers
Biotechnologists, Pharmaceutical Researchers, Drug Discovery Scientists, Structural Biologists, Academic Research Institutions Biotechnology Companies, Cancer Researchers, Pharmaceutical Companies, Agricultural Biotechnology Firms, Infectious Disease Research Labs, Genomic Research Institutions, AI Drug Discovery Researchers
Taxonomy
Protein ScienceMultiplex Protein ScreeningCell-free Expression SystemsDigital MicrofluidicsProtein CharacterizationDrug Discovery +9 Synthetic BiologyDNA SynthesisGene SynthesisCRISPRDrug DiscoveryNext Gen Sequencing +8
Website
nuclera.com twistbioscience.com
Nuclera logo

About Nuclera

Nuclera, founded in 2013 by PhD students at the University of Cambridge, has positioned itself as a transformative player in the biotechnology, life sciences, and pharmaceutical industries. With its headquarters in the United Kingdom and a burgeoning presence in Boston, MA, the company employs over...

Twist Bioscience logo

About Twist Bioscience

Twist Bioscience, a leading force in synthetic biology, is based in South San Francisco, California. Founded in 2013, the company's mission—a resonant "Synthetic DNA for Health & Sustainability"—is to empower life science research across diverse fields such as medicine, agriculture, and industrial c...

Also comparing in this category

Comparing more than these two?

Get Nuclera, Twist Bioscience and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Nuclera compare?

A PDF of Nuclera and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

Nuclera was founded in 2013, based in Cambridge, United Kingdom, with 108 employees. Nuclera, founded in 2013 by PhD students at the University of Cambridge, has positioned itself as a transformative player in the biotechnology, life sciences, and pharmaceutical industries. With its h. Twist Bioscience was founded in 2013, based in South San Francisco, United States, with 1,317 employees. Twist Bioscience, a leading force in synthetic biology, is based in South San Francisco, California. Founded in 2013, the company's mission—a resonant "Synthetic DNA for Health & Sustainability"—is to.
Nuclera has raised $207.83M and Twist Bioscience $943.10M. Latest stage: Nuclera Series C, Twist Bioscience IPO.
Both work in Biotechnology and Life Sciences and list drug discovery among their focus areas.

Compare Nuclera with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Nuclera on 15 Jun 2026, and Twist Bioscience on 26 Aug 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes